share_log

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

周一生物技术催化剂综述-当天结束摘要
Benzinga Real-time News ·  2022/08/22 19:14
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet's (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares versus three months average volume of 476.99 thousand shares, closed regular trading session at $261.89.
美国食品和药物管理局(FDA)已宣布批准Insulet纳斯达克的OmniPod 5自动胰岛素递送系统(OmniPod 5)适用于两岁及以上的1型糖尿病(T1D)患者。Insulet的股票当日成交量为200.86万股,而三个月平均成交量为476.99万股,收盘时常规交易时段为261.89美元。
Pfizer (NYSE:PFE) and BioNtech SE (NASDAQ:BNTX) have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals...
辉瑞公司(纽约证券交易所股票代码:PFE)和BioNTech SE纳斯达克公司(S...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发